CVS Health's operating cash flow stood at USD 7,119 mil in 2Q2020, up 33.4% when compared to the previous year. Historically, between 1Q2010 - 2Q2020, the firm’s operating cash flow reached a high of USD 7,119 mil in 2Q2020 and a low of USD -136 mil in 4Q2017.
CVS Health's total investments stood at USD -1,333 mil and accounted for 0.686% of sales in 2Q2020. This is compared to an average of 1.13% as seen over the last five years.
Cash from financing amounted to USD -978 mil, so the company generated USD 4,808 mil net cash in 2Q2020.
At the end of 2Q2020, the company had a net debt of USD 74,586 mil, or 3.77x of EBITDA and 109% of equity. Net working capital amounted to USD 21,758 mil, or 33.3% of sales. Cash conversion cycle is negative and reached 29.9 days days in 2Q2020. This means CVS Health generates revenue from customers before it has to pay its suppliers for inventory, among other things.
|Total Cash From Operations||Unit||Mar 2008||Jun 2008||Sep 2008||Dec 2008||Mar 2009||Jun 2009||Sep 2009||Dec 2009||Mar 2010||Jun 2010||Sep 2010||Dec 2010||Mar 2011||Jun 2011||Sep 2011||Dec 2011||Mar 2012||Jun 2012||Sep 2012||Dec 2012||Mar 2013||Jun 2013||Sep 2013||Dec 2013||Mar 2014||Jun 2014||Sep 2014||Dec 2014||Mar 2015||Jun 2015||Sep 2015||Dec 2015||Mar 2016||Jun 2016||Sep 2016||Dec 2016||Mar 2017||Jun 2017||Sep 2017||Dec 2017||Mar 2018||Jun 2018||Sep 2018||Dec 2018||Mar 2019||Jun 2019||Sep 2019||Dec 2019||Mar 2020||Jun 2020|
|CVS Health||USD mil||...||...||...||...||...||...||...||...||2,479||1,948||5,338||2,928||2,634|